Hatem Ashraf, Mohamed Sherif, Abu Elhassan Usama E, Ismael Eman A M, Rizk Magda S, El-Kholy Amany, El-Harras Mohamed
1Department of Chest Diseases, Faculty of Medicine, Cairo University, Cairo, Egypt.
2Department of Chest Diseases and Tuberculosis, Faculty of Medicine, Assiut University, Assiut, 71516 Egypt.
Multidiscip Respir Med. 2019 Apr 1;14:11. doi: 10.1186/s40248-019-0174-7. eCollection 2019.
Respiratory viral and atypical bacterial infections data in Egyptian patients are sparse. This study describes the clinical features and outcomes of patients with severe acute respiratory infections (SARI) in hospitalized patients in Egypt.
SARI surveillance was implemented at Cairo University Hospital (CUH) during the period 2010-2014. All hospitalized patients meeting the WHO case definition for SARI were enrolled. Nasopharyngeal/oropharyngeal (NP/OP) swabs were collected and samples were tested using RT-PCR for influenza A, B, respiratory syncytial virus (RSV), human metapneumovirus (hMPV), parainfluenza virus (PIV 1,2,3,4), adenovirus, bocavirus, coronavirus, enterovirus, rhinovirus, and atypical bacteria. Data were analyzed to calculate positivity rates for viral pathogens and determine which pathogens related to severe outcomes or resulted in death.
Overall, 1,075/3,207 (33.5%) cases had a viral etiology, with a mean age of 5.74 (±13.87) years. The highest rates were reported for RSV (485 cases, 45.2%), PIV (125, 11.6%), and adenovirus (105, 9.8%). Children had a higher viral rate (981, 91.2%) compared to 94 (8.8%) cases in adults. Patients with identified viruses had significantly lower rates for ICU admission, hospital stay, mechanical ventilation, and overall mortality than those without identified viruses. No infections were independently associated with severe outcomes.
Viral pathogens were encountered in one-third of hospitalized adult and pediatric Egyptian patients with SARI, while atypical bacteria had a minor role. Highest rates of viral infections were reported for RSV, PIV, and adenovirus. Viral infections had neither negative impacts on clinical features nor outcomes of patients with SARI in our locality.
埃及患者中呼吸道病毒和非典型细菌感染的数据较为稀少。本研究描述了埃及住院患者中严重急性呼吸道感染(SARI)患者的临床特征及转归。
2010年至2014年期间在开罗大学医院(CUH)开展了SARI监测。纳入所有符合WHO SARI病例定义的住院患者。采集鼻咽/口咽(NP/OP)拭子,样本采用逆转录聚合酶链反应(RT-PCR)检测甲型、乙型流感病毒、呼吸道合胞病毒(RSV)、人偏肺病毒(hMPV)、副流感病毒(PIV 1、2、3、4)、腺病毒、博卡病毒、冠状病毒、肠道病毒、鼻病毒及非典型细菌。分析数据以计算病毒病原体的阳性率,并确定哪些病原体与严重转归或死亡相关。
总体而言,1075/3207例(33.5%)病例有病毒病因,平均年龄为5.74(±13.87)岁。RSV感染率最高(485例,45.2%),其次是PIV(125例,11.6%)和腺病毒(105例,9.8%)。儿童的病毒感染率(981例,91.2%)高于成人(94例,8.8%)。确诊病毒感染的患者入住重症监护病房(ICU)、住院时间、机械通气及总体死亡率均显著低于未确诊病毒感染的患者。未发现任何感染与严重转归独立相关。
在埃及住院的成人和儿童SARI患者中,三分之一存在病毒病原体感染,而非典型细菌感染的作用较小。RSV、PIV和腺病毒的病毒感染率最高。在我们当地,病毒感染对SARI患者的临床特征和转归均无负面影响。